Radiomics Analysis on Noncontrast CT for Distinguishing Hepatic Hemangioma (HH) and Hepatocellular Carcinoma (HCC)

<div>Decision curve analysis of radiomics signature and radiomics index. The <i>Y</i>-axis represents the net benefit. The radiomics index provided more clinical benefits than treating all or none of the patients, and the radiomics signature.</div>

Contrast Media & Molecular Imaging

fig5

Figure 5

Figure 5: Radiomics Analysis on Noncontrast CT for Distinguishing Hepatic Hemangioma (HH) and Hepatocellular Carcinoma (HCC) 